Search results for " monitoring."

showing 10 items of 2717 documents

Impaired exercise tolerance is associated with increased urine albumin excretion in the early stages of essential hypertension

2011

Background: Our aim was to investigate the relationship between impaired exercise capacity and albumin excretion level in the setting of never treated essential hypertension. Design and methods: For this purpose, 338 consecutive essential hypertensives (52 ± 8.5 years, 227 males, office BP = 148.6/96.1 mmHg) performed a negative for myocardial ischemia, maximal treadmill exercise testing and were classified based on the gender specific median value of the amount of metabolic equivalents (METs) achieved (10.1 ml/kg/min for women and 11 ml/kg/min for men) as fit ( n = 177) and unfit ( n = 161). All the participants underwent 24-h ambulatory BP monitoring, complete echocardiographic study inc…

AdultMalemedicine.medical_specialtyTime FactorsAmbulatory blood pressureUrinalysisEpidemiologyBlood PressureUrinalysisEssential hypertensionRisk AssessmentVentricular Function LeftMetabolic equivalentPredictive Value of TestsRisk FactorsInternal medicinePrevalenceAlbuminuriaHumansMedicineAnalysis of VarianceChi-Square DistributionExercise ToleranceGreecemedicine.diagnostic_testbusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseAdaptation PhysiologicalEchocardiography DopplerCross-Sectional StudiesBlood pressureHypertensionDisease ProgressionExercise TestLinear ModelsAlbuminuriaCardiologyFemaleMicroalbuminuriamedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexEuropean Journal of Preventive Cardiology
researchProduct

Implantation Strategy of the Atrial Dipole Impacts Atrial Sensing Performance of Single Lead VDD Pacemakers

2002

WIEGAND, U.K.H., et al.: Implantation Strategy of the Atrial Dipole Impacts Atrial Sensing Perfor-mance of Single Lead VDD Pacemakers. Intermittent atrial undersensing is observed in a considerable percentage of patients with single lead VDD pacemakers. Analyzing the 2-year data of the Saphir Multicenter Follow-Up Study, the authors investigated predictors for the occurrence of undersensing. The study included 194 patients with high degree AV block who received a VDD pacemaker system with an identical sensing amplifier. Placement strategy of the atrial dipole was left to the discretion of the implanting physician. At the final position, atrial potential amplitudes were measured during deep …

AdultMalemedicine.medical_specialtyTime FactorsAtrial sensingSensitivity and SpecificityPacemaker systemElectrocardiographyIntraoperative fluoroscopyInternal medicineHumansMulticenter Studies as TopicMedicineHeart Atriacardiovascular diseasesAgedRetrospective StudiesAged 80 and overbusiness.industryP waveCardiac Pacing ArtificialEquipment DesignGeneral MedicineMiddle AgedDipoleHeart Blockmedicine.anatomical_structureSingle leadAtrioventricular Nodecardiovascular systemCardiologyRight atriumEquipment FailureFemaleCardiology and Cardiovascular MedicinebusinessHolter monitoringFollow-Up StudiesPacing and Clinical Electrophysiology
researchProduct

Results of the performance verification of the CoaguChek XS system.

2008

Abstract Background This is the first paper reporting a performance verification study of a point-of-care (POC) monitor for prothrombin time (PT) testing according to the requirements given in chapter 8 of the International Organization for Standardization (ISO) 17593:2007 standard “Clinical laboratory testing and in vitro medical devices — Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy”. The monitor under investigation was the new CoaguChek XS system which is designed for use in patient self testing. Its detection principle is based on the amperometric measurement of the thrombin activity generated by starting the coagulation cascade using a rec…

AdultMalemedicine.medical_specialtyTime FactorsCoefficient of variationPoint-of-Care SystemsThromboplastinYoung AdultCoagulation cascadeAcceptance testingReference ValuesmedicineHumansIn patientInternational Normalized RatioBlood testingBlood CoagulationOral anticoagulationAgedReagent StripsProthrombin timeAged 80 and overmedicine.diagnostic_testbusiness.industryAnticoagulantsHematologyMiddle AgedRecombinant ProteinsSurgerySelf CareOral anticoagulantProthrombin TimeFemaleDrug MonitoringbusinessBiomedical engineeringThrombosis research
researchProduct

Clinical evaluation of a wireless ECG sensor system for arrhythmia diagnostic purposes

2013

Accepted version of an article in the journal: Medical Engineering and Physics. Also available from the publisher at: http://dx.doi.org/10.1016/j.medengphy.2013.03.002 In a clinical study, a novel wireless electrocardiogram (ECG) recorder has been evaluated with regard to its ability to perform arrhythmia diagnostics. As the ECG recorder will detect a "non-standard" ECG signal, it has been necessary to compare those signals to "standard" ECG recording signals in order to evaluate the arrhythmia detection ability of the new system. Simultaneous recording of ECG signals from both the new wireless ECG recorder and a conventional Holter recorder was compared by two independent cardiology specia…

AdultMalemedicine.medical_specialtyambulatory electrocardiographyBiomedical EngineeringBiophysicsElectrocardiographyYoung Adultevaluation studiesmedicineHumansWirelessMedical physicscardiovascular diseasesChildReference standardsAgedAmbulatory electrocardiographySensor systemclinical trialsbusiness.industryReproducibility of ResultsArrhythmias CardiacSignal Processing Computer-AssistedVDP::Technology: 500::Information and communication technology: 550Middle AgedReference StandardsHolter monitoringClinical trialVDP::Medical disciplines: 700wireless ECG sensorFemalebusinessTelecommunicationsWireless TechnologyClinical evaluationHolter monitoring
researchProduct

Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients

2019

Objective: Atrial fibrillation (AF) is a major cause for recurrent stroke, has severe impact on a patient's health and imposes a high economic burden for society. Current guidelines recommend 24 h ECG monitoring (standard-of-care, SoC) to detect AF after stroke to reduce the risk of future events. However, paroxysmal AF (PAF) is difficult to detect within this period as it occurs infrequently and unpredictably. In a randomized controlled trial (Find-AF(RANDOMISED)), prolonged and enhanced Holter ECG monitoring (EPM) revealed a significantly higher detection rate of AF compared to SoC, although its cost-effectiveness has not yet been investigated. Methods: Based on the data of FIND-AF(RANDOM…

AdultMalemedicine.medical_specialtymacromolecular substancesCOST-EFFECTIVENESS ANALYSIS030204 cardiovascular system & hematologyGUIDELINESTHERAPYBrain Ischemia03 medical and health sciences0302 clinical medicineRecurrent strokeInternal medicinemedicineMANAGEMENTHumanscardiovascular diseases030212 general & internal medicinequality-adjusted life yearsAcute ischemic strokeStrokeAgedAged 80 and overbusiness.industrycost-benefit analysisAtrial fibrillationGeneral MedicineCost-effectiveness analysisMiddle AgedWirtschaftswissenschaftenmedicine.diseaseAtrial fibrillationstroke3. Good healthQuality-adjusted life yearTRIALSEconomic evaluationATRIAL-FIBRILLATIONCardiologyElectrocardiography AmbulatoryQuality of LifeFemalebusinessHolter monitoringsecondary preventionTASK-FORCE
researchProduct

Repeated sugammadex reversal of muscle relaxation during lumbar spine surgery with intraoperative neurophysiological multimodal monitoring

2016

Intraoperative neurophysiological monitoring during spine surgery is usually acomplished avoiding muscle relaxants. A case of intraoperative sugammadex partial reversal of the neuromuscular blockade allowing adequate monitoring during spine surgery is presented. A 38 year-old man was scheduled for discectomy and vertebral arthrodesis throughout anterior and posterior approaches. Anesthesia consisted of total intravenous anesthesia plus rocuronium. Intraoperatively monitoring was needed, and the muscle relaxant reverted twice with low dose sugammadex in order to obtain adequate responses. The doses of sugammadex used were conservatively selected (0.1 mg/kg boluses increases, total dose neede…

AdultMalemedicine.medical_specialtymedicine.drug_classMuscle RelaxationContext (language use)Critical Care and Intensive Care MedicineSugammadexSugammadexAnestesia03 medical and health sciencesSpine surgery0302 clinical medicine030202 anesthesiologyIntraoperative neurophysiological monitoringHumansMedicineAnesthesiaAndrostanolsNeuromuscular blocking drugsRocuroniumMonitorizacion neurofisiologica intraoperatoriaNeuromuscular BlockadeLumbar Vertebraebusiness.industryMuscle relaxantCirugia de raquisFarmacos bloqueantes neuromuscularesNeuromuscular Nondepolarizing AgentsSurgeryAnesthesiology and Pain MedicineMuscle relaxationRocuronioAnesthesiaNeuromuscular BlockadeRocuroniumbusiness030217 neurology & neurosurgeryNeuromuscular Nondepolarizing Agentsgamma-Cyclodextrinsmedicine.drugIntraoperative neurophysiological monitoringRevista Española de Anestesiología y Reanimación
researchProduct

Therapeutic Drug Monitoring of the Antidepressant Mirtazapine and Its N-Demethylated Metabolite in Human Serum

2004

Mirtazapine is a novel antidepressant that acts by enhancing serotonergic and noradrenergic neurotransmission. Because very little is known about serum concentrations in relation to clinical effects, the use of therapeutic drug monitoring is so far unclear. A rapid automated HPLC method with fluorescence detection was developed for routine quantification of mirtazapine and its demethylated metabolite N-desmethylmirtazapine in human serum. The precision of the method was suitable because the day-to-day (n = 7) coefficient of variation (CV) of mirtazapine was 9.8, 4.2, and 5.1% for concentrations of 10, 40, and 80 ng/mL, respectively, and the CV for N-desmethylmirtazapine were 11.6, 10.3, and…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentMetaboliteCoefficient of variationMirtazapineMirtazapineMianserinPharmacologySensitivity and Specificitychemistry.chemical_compoundInternal medicinemedicineHumansPharmacology (medical)AmisulprideAntipsychoticChromatography High Pressure LiquidAgedPharmacologySertralinemedicine.diagnostic_testbusiness.industryMiddle AgedEndocrinologychemistryTherapeutic drug monitoringHistamine H1 AntagonistsAntidepressantFemaleDrug Monitoringbusinessmedicine.drugTherapeutic Drug Monitoring
researchProduct

External and internal exposure to polycyclic aromatic hydrocarbons (PAH) among workers in the production of fire-proof materials – Proposal of a biol…

2006

In 1999, we introduced the German polycyclic aromatic hydrocarbons (PAH) study. The study was designed as a nation-wide investigation on workers exposed to PAH. One aim of the study was to establish biological monitoring guidance values (BMGVs) for different branches. Here, we report on the production of fire-proof materials. This branch of industry is typically confronted with high exposure to PAH and with PAH-induced occupational (cancer) diseases. One hundred and thirty-five employees participated in the course of seven sampling dates in four different plants in Germany. External exposure was determined by personal air monitoring of the 16 EPA-PAH. Human biological monitoring was accompl…

AdultPercentilePopulationAir Pollutants OccupationalUrinechemistry.chemical_compoundAir monitoringGermanyOccupational ExposureHumansIndustryPolycyclic Aromatic HydrocarbonsThreshold Limit ValueseducationCreatinineeducation.field_of_studyPyrenesSmokingPublic Health Environmental and Occupational HealthMiddle AgedPhenanthrenesPah exposureSpot urinechemistryEnvironmental chemistryPyreneEnvironmental MonitoringInternational Journal of Hygiene and Environmental Health
researchProduct

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris

1996

Percutaneous transluminal coronary angioplasty is often complicated by thrombotic abrupt vessel closure in patients with unstable angina pectoris. The present multicentre trial was performed to determine the feasibility of two-dose regimens of recombinant hirudin (r-hirudin) compared to standard heparin in patients undergoing coronary angioplasty for unstable angina, and to investigate the effects of the different treatment regimen on markers of coagulation activation. At five participating centres, 61 patients were randomly enrolled in one of two sequential groups of r-hirudin (group 1: 0.3 mg.kg-1 i.v. bolus, 0.12 mg.kg-1.h-1 i.v. infusion; 21 patients; group 2: 0.5 mg.kg-1 i.v. bolus, 0.…

Adultmedicine.drug_classmedicine.medical_treatmentHirudinEnzyme-Linked Immunosorbent AssayAnginaFibrinolytic AgentsmedicineHumansAngina UnstableAngioplasty Balloon CoronaryInfusions IntravenousBlood CoagulationAgedBlood coagulation testDose-Response Relationship Drugmedicine.diagnostic_testHeparinUnstable anginabusiness.industryAnticoagulantThrombinAnticoagulantsPercutaneous coronary interventionHeparinHirudinsMiddle Agedmedicine.diseaseRecombinant ProteinsAnesthesiaPartial Thromboplastin TimeDrug MonitoringCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugPartial thromboplastin timeEuropean Heart Journal
researchProduct

Increase in Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1 Diabetes

2002

Patients with type 1 diabetes mellitus and microalbuminuria often have elevated blood pressure while they are asleep, but it is not known whether the elevation develops concomitantly with microalbuminuria or precedes it.We monitored 75 adolescents and young adults who had had type 1 diabetes with normal urinary albumin excretion and blood pressure for more than five years. Ambulatory blood-pressure monitoring was used to assess blood pressure at the initial evaluation and about two years later, at which time all subjects had normal urinary albumin excretion. Subsequently, subjects were monitored for the development of microalbuminuria.Microalbuminuria developed in 14 subjects, whereas the o…

Adultmedicine.medical_specialtyAdolescentBlood PressureExcretionInternal medicineDiabetes mellitusmedicineAlbuminuriaHumansProspective StudiesGlycated HemoglobinType 1 diabetesProteinuriabusiness.industryAlbuminGeneral MedicineBlood Pressure Monitoring Ambulatorymedicine.diseaseCircadian RhythmDiabetes Mellitus Type 1EndocrinologyBlood pressureAmbulatoryDisease ProgressionCardiologyMicroalbuminuriamedicine.symptombusinessBiomarkersNew England Journal of Medicine
researchProduct